Lazar Dimitrov

Director/Board Member at Lumos Pharma Sub, Inc.

Consumer Services

Finance

Health Services

Profile

Dr. Lazar Dimitrov is a Principal at Clarus Ventures LLC.
She received her undergraduate degree from Dartmouth College and a graduate degree from the University of Washington.

Lazar Dimitrov active positions

Companies	Position	Start
Lumos Pharma Sub, Inc. Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.	Director/Board Member	-

All active positions of Lazar Dimitrov

Former positions of Lazar Dimitrov

Companies	Position	End
Clarus Ventures LLC Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts.	Private Equity Analyst	-

See the detail of Lazar Dimitrov's experience

Training of Lazar Dimitrov

Dartmouth College	Undergraduate Degree
University of Washington	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lazar Dimitrov's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Clarus Ventures LLC Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts.	Finance
Lumos Pharma Sub, Inc. Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.	Health Services